Placebo Response in Moderate-to-Severe Psoriasis: Prevalence Meta-Analysis of Randomized Controlled Trials

J Invest Dermatol. 2023 Jun;143(6):1101-1104. doi: 10.1016/j.jid.2022.10.024. Epub 2022 Dec 21.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Double-Blind Method
  • Humans
  • Placebo Effect
  • Prevalence
  • Psoriasis* / drug therapy
  • Psoriasis* / epidemiology
  • Randomized Controlled Trials as Topic
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal